Micro Flashcards

(77 cards)

1
Q

Decrease abx peak concentration

A

Reduced gut absorption
Increased Vd
Reduced penetration to site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Increase Abx peak concentration

A

Reduced protein binding

Reduced clearance mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Increase Abx t 1/2

A

Decreased renal or hepatic clearance

Decreased overall metabolism eg hypothermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Decrease Abx t1/2

A

RRT
INCREASED hepatic clearance
Increased glomerular filtration
Increased drug metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ways that critical illness can change pharmacokinetics and dynamics of Abx

A

Enhanced organ toxicity due to poor clearance and increased risk of damage to organs directly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does shock affect pharmacokinetics and dynamics of Abx

A

Increased Vd
Decreased bioavailability of basic drugs (due to increase in alpha 1 glycoproteins)
Increased penetration of formerly impenetratable tissue eg meningitis
Impaired hepatic metabolism due to inhibited cyp 450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
In renal failure you would..... For
Beta lactams
Carbapebems
Aminoglycosides
Fluriquinolones
Glycopeptides
A

BL - can be dose of interval adjusted
Carb - as above
Amino - same dose, interval adjust, check levels
Fluor - same dose, interval adjust, check QT
Glycopeptides - same dose, interval adjust, check levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Interval adjusting is most relevant for;

A

Concentration dependent abx which have toxicity with high levels
Examples - amino glycosides and Glycopeptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why do you dose adjust Abx

A

Relevant for time dependent abX that have toxicity associated with high concentration peaks
Eg fluroquinolones

Important to be above MIC for as long as possible - only need to load and then give small frequent doses to remain above MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Abx that rely on renal clearance

A
Beta lactams, cephalosporins and car spends
Amino glycosides
Fluconazole
Aciclovir
Vanc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Abx that do not need adjustment with renal failure

A
Linezolid
Clindamycin
Amphoteracin
Azitgromyxib
Ceftriaxome
Voriconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

General principles of abx dose adjusting in CRRT

A

Abx with time dependent killing - if rapidly cleared by CRRT need to give more frequently

Abx with concentration dependent killing - if cleared rapidly dose should be increased

If RRT is intermittent eg SLED should give at the end of each session

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs with large Vd, which do not rely on renal clearance

Eg - don’t need changes with RRT

A
Ceftriaxone
Moxifloxacin
Clindamycin
Linezolid
Voriconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs that have large Vd and rely on renal clearance - need to have increased dosing interval as the filter can’t act the same way as the kidney with active pumps

A

Levofloxacin
Ciprofloxacin
Colostin
Amphiteracin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs with small Vd that do rely on renal clearance - doe shouldn’t be adjusted with RRT as the filter can act as kidney in terms of glomerular filtration action

A
Beta lactams
Carbapenems
Amino glycosides
Glycopeptides
Fluconazole

MAY need to increase dose as filter may be more efficient esp fluconazole which must be increased at high filter rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Time dependent Abx

A
Beta lactams
Carbapenems
Monobactams
Linezolid
Clindamycin
Macrolides

Abx that kill bacteria most effectively when the bacteria are about to divide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Concentration dependent killing abx

A

Amino glycosides
Metronidazole
Daptomycin

Drugs that affect bacterial metabolism or protein synthesis; higher concentration means more enzyme molecules are inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Time and concentration dependent killing

A
Fluroquinolones
Azithromycin
Tetracyclines
Vanc
Tigecycline

Drugs that inhibit DNA synthesis or other components of cellular division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why are Abx not working

A

Wrong dose
Delayed dose
Inadequate source control
Inadequate blood levels
Inadequate penetration
Anti microbial neutralisation or antagonism
Superinfection or unsuspected secondary infection
Non bacterial infection
Non infectious source of illness
Eagle effect - paradoxical loss of effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Factors that influence Abx choice

A

Disease factors - travel hx, occupation, ivdu, reliability of cultures
Host factors - age, allergies, pregnancy
Organism factors - source control, susectibility,
Drug factors - cost, toxicity, drug synergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MIC definition

A

The lowest concentration of an antimicrobial that will inhibit visible growth of an organism after overnight incubation

Lower MIC = more effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Drugs with post antibiotic effect

A
Those with concentration dependent kill characteristics;
Amino glycosides
Clindamycin
Macro life's
Tetracyclines
Rifampicin
Dalfopristin

Is when effects are seen long after concentration below MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Drugs with no post Abx effect

A

Beta lactams
Cephalosporins
Monobactams

These would benefit from continuous infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Polyenes

A

Antifungals - Amphiteracin and nystatin

They weaken cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Amphiteracin
Active against fungi and yeast Large Vd No reliance on renal clearance Toxicity - nephrotoxic, hypokalaemia, fever Ags chills, RTA, hypochromic normocytic anaemia
26
Azoles
Antifungals Fluconazole, Voriconazole Prevent synthesis of ergosterol Early generations are only active against candida albicans and, most non albicans and are resistant
27
Fluconazole
``` Candida albicans Other candida resistant Active against cryptococcus No activity against aspergillus Penetrates into CSF Small Vd Relies on renal clearance, readily cleared by dialysis Toxicity - LFTS, alopecia, drug interactions (inhibits CYP 450) ``` Prophylaxis - use does not reduce mortality IV surgical pts May reduce mortality if given in septic shock
28
Voriconazole
Covers all candida, cryptococcus, aspergillus Highly protein bound Vd massive Not renally cleared, not dialysable Inhibits CYP 450 Toxicity - long Qt, hallucinations, psychosis, drug interaction
29
Echinocandins
Anti fungal eg caspofungin Inhibit cell wall synthesis by blocking synthesis of glycine 1,3 beta glucose synthase Very active against candida, useless for cryptococcus, not very helpful for aspergillus Highly protein bound But dependent on renal excretion, not dialysable Minimal toxicity
30
Toxicities of linezolid
``` Thrombocytopaenia Anaemia Neuropathy Lactic acidosis Serotonin syndrome ``` All due to mitochondrial toxin activity
31
Teicoplanin toxicity
Renal or liver dysfunction Thrombocytopaenia Anaemia
32
Tigecycline toxicities/se's
N&V, | Teratogenic
33
Daptpmycin toxicity
Myopathy
34
Indicators of severity in CAP
``` Minor- RR >30 PF <250 confusion raised urea low WCC low plat low temp low BP ``` Major - - invasive ventilation - need for vasopressors
35
Slow reponders to treatment in pneumonia
``` aspergillus Q fever TB nocardia leptospirosis melioidosis ```
36
Risks for VRE
``` long admission renal impariment enteral tube feeding proximity to VRE patients elderly long term IV access inter hospital transfer low staff:patient ratio haematological malignancy multiple courses of Abx ```
37
Risks for C diff
``` Abx exposure - cipro ,clinda, beta lactams, cephalo immunosuppresant drugs, cytotoxic drugs age >65 PPI renal impairment long admission ```
38
treatment of VRE
linezolid teicoplanin (if Van B) daptomycin tigecycline
39
consequences of VRE
systemic infection - determined by site of infection | transfer of resistance to staph aureus
40
qSOFA pros and cons
Easy Has good predictive validity (AUROC 0.81) BUT - - validated retrospectively - "new onset" vs old changes?? - not proven to be valid in a range of clinical settings
41
non-albicans candidaemia is associated with;
``` Repeated abdominal surgeries Exposure to broad-spectrum antibiotics Exposure to fluconazole Diabetes CVC insertion TPN use Malignancy Renal failure ```
42
Complications of candidaemia
``` Candida endopthalimitis/retinitis Candia endocarditis Hepatosplenic abscesses Pulmonary cavitating lesions CNS involvement (meningitis or abscesses) Candida arthritis ```
43
Lab confirmation of malaria
Thick (parasite load) and thin (parasite species) blood smears Rapid diagnostic tests utilising malarial antigens (dependents on specific test)
44
firstline drugs for malaria
``` Cinchona alkaloids (quinine and quinidine) Artemisinin derivatives (artesunate, artemether). ``` Also - tetracyclines (eg doxycycline), napthoquinones (eg. atovaquone) and lincosamides (eg. clindamycin).
45
Acute complications of malaria
Cerebral Involvement with or without convulsions Respiratory Failure - acute respiratory distress syndrome (ARDS) Circulatory collapse ``` GI - • Renal failure, hemoglobinuria ("black water fever") • Hepatic failure • Splenic Rupture - hepatosplenomegaly ``` Haematological • Disseminated intravascular coagulation • Severe anemia secondary to Haemaolysis • Thrombocytopenia ``` Metabolic • Hypoglycemia • Severe Acidosis • Hyponatraemia -high fever and rhabdo due to rigors ```
46
Steps to take if approaching Ix of increase in infection rate (eg MRSA)
Investigate the validity of the reported colonisation rate Investigate the demographics of the colonised patients Investigate the origin of the patients (which ward are they coming from?) Revisit the current infection control policy: is it time to rewrite it? Get expert opinions from infectious diseases and infection control specialists Form a multidisciplinary review panel (ICU specilists, ID physicians, NUMS and RNs) Review the current literature on infection control Rewrite infection control policy Educate the staff regarding the new policy Implement rigorous standards regarding hand washing and bed space cleaning Monitor the effects of the implemented policies
47
differential causes of puprura fulminans
DIC from any cause Sepsis due to the following organisms: - S.pneumoniae - but mainly in asplenic patients for some reason - S.aureus - H.influenzae - N.meningitides Endocarditis of any bacterial aetiology MAHA (microangiopathic haemolytic anaemia) TTP (thrombotic thrombocytopenic purpura) Varicella infection Rickettsial infection Plasmodium falciparum malaria Vasopressor excess Warfarin-induced skin necrosis Congenital Protein C anticoagulant pathway defect Post-infectious purpura fulminans (due to autoimmune destruction of proteins C or S)
48
Risk factors for CMV in the immunocompetent host
Critical illness in general seems to be a risk factor. Risk factors for reactivation: - Trauma - Burns - Severe critical illness (high APACHE score, over 27) - Blood transfusion - Mechanical ventilation - Severe sepsis - Prolonged ICU stay - Pregnancy
49
diagnosis of CMV
Positive CMV antibodies (IgM) - sensitive for recent or acute infection Qualitative PCR - very sensitive for the presence of CMV, but they do not distingusih between active and latent infection. Quantitative PCR - ideal test, as it provides a quantitative assessment of viral load, and allows the monitoring of therapy.
50
complications of CMV
``` Colitis Hepatitis Encephalitis Guillain-Barre syndrome Pneumonitis (rare) Pericarditis and myocarditis Uveitis and retinitis ```
51
Complications of CMV in the Immunocompromised (transplant) host
Chronic allograft nephropathy (renal transplant) Hepatic artery thrombosis (liver transplant) Accelerated Hep C recurrence (liver transplant) Bronchiolitis obliterans (lung transplant) New onset NIDDM Post-transplant lymphoproliferative disease
52
Management of CMV infection
Ganciclovir - initially valganciclovir - when infection under control Resistant strains - foscarnet and cidofovir
53
Virology of CMV
May be present in breast milk, saliva, feces, and urine. Not readily spread by casual contact. Requires prolonged or intimate exposure. Once infected, it is carried for life. Reactivation occurs when T-cell immunity is impaired. In organ transplant recipients, the transplanted organ is often the reservoir.
54
"Cytomegalovirus" is so called because... (interesting facts - because i dont have enough to learn)
the affected cells are two to four times the size of unaffected cells. These cells typically have large "owl's eye" inclusions
55
treatment options from MRSA aside from vanc
Tigecycline Linezolid (particularly for MRSA pneumonia, where vancomycin penetrates poorly) Quinupristin/dalfopristin Daptomycin Fosfomycin (usually to enhance the effects of other drugs) Rifampicin/fusidic acid (particularly for deep bone and joint infections) Telavancin, dalbavancin and oritavancin Ceftobiprole and ceftaroline Iclaprim Trimethoprim/sulfamethoxazole Moxifloxacin
56
Non infectious causes of fever
Vascular - Cerebral infarction/hemorrhage - Myocardial infarction - Ischemic bowel - Subarachnoid hemorrhage - Fat emboli - Deep venous thrombosis/PE - Phlebitis/thrombophlebitis Neoplastic - Lymphoma-associated fever - Renal cell carcinoma - Tumour lysis syndrome Drug-induced - Alcohol/drug withdrawal - Drug fever Idiopathic inflammatory - Postoperative fever (48 h postoperative) - Acalculous cholecystitis - Pancreatitis - Aspiration pneumonitis - ARDS - Gout/pseudogout - IV contrast reaction - GI bleed Autoimmune - Posttransfusion fever - Transplant rejection - Vasculitis - Haemolytic anaemia Traumatic/environmental - Haematoma degradation - Decubitus ulcers - Heat stroke Endocrine - Adrenal insufficiency - Thyrotoxicosis - Thyroiditis (Hashimoto) - Ovulation/pregnancy
57
Biochemical markers of sepsis include:
``` CRP Procalcitonin LPS-binding protein sTREM-1 Presepsin (sCD14-st) HMGB-1 ```
58
mechanisms that lead to vasodilation in sepsis
Nitric oxide synthase induction by cytokines and endotoxin Direct vascular smooth muscle response to acidosis and hypoxia Inflammatory mediators produced by activated leucocytes Vasodilatory mediators (eg. histamine bradykinin and serotonin) produced by leukocytes and platelets Relative vasopressin deficiency Relative adrenal insufficiency, resulting in peripheral catecholamine insensitivity Acidosis, resulting in peripheral catecholamine insensitivity
59
Opportunistic infections and treatment
CMV - valganciclovir Aspergillus - voriconizole or amphoteracin Pneumocystis - bactrim Nocardia - suphonamides
60
risk factors for Varicella pneumonia:
``` Immunocompromised Pregnancy Chronic lung disease Adults (greater risk compared to children) Smoking Number of spots - over 100 ```
61
Causes of seizures in meningitis
cerebritis cerebral venous sinus thrombus increased intracranial pressure abscess
62
causes of functional asplenia
sickle cell disease alcoholic liver disease coeliac disease
63
Risk factors for pneumococcal bacteraemia
``` Extreme of age <2 or >65 Chronic lung disease Asplenia both functional and anatomic Immunosuppression Transplant patients CSF leaks Cochlear implants ```
64
Risk factors for acalculous cholecystitis
``` Trauma with massive transfusion Any recent surgery Burns Sepsis TPN Prolonged fasting Critical illness in general ```
65
Radiological and Ultrasonographic Features of | Acalculous Cholecystitis
``` Thickened gall bladder wall (over 3.5-4mm) Pericholecystic fluid Intramural gas Echogenic or hyperdense bile sludge Sloughed mucosa Gall bladder distension ```
66
Pathogens commonly responsible for acalculous cholecystitis
``` E.coli Klebsiella Proteus Enterococcus Bacteroides ```
67
treatment of prosthetic valve IE
vancomycin, gentamicin and rifampicin
68
stereotypical criteria for toxic shock syndrome
High fever (> 38.9°) Hypotension and shock Rash consistent with diffuse macular erythroderma Desquamation, particularly of the palms and soles There are also non-diagnostic associated features: Rapid onset: ~ 2 days Staphylococcus may grow in the blood (but blood cultures otherwise negative) Multisystem organ involvement
69
Pathogenesis of toxic shock syndrome
Some staphylococci produce a characteristic protein (the Toxic Shock Syndrome Toxin, or TSST-1, 2 and 3). TSST activates T-cells directly, acting as a "superantigen" -> Massive inflammatory cytokine release Endothelial dysfunction and vasodilatory shock ensues, which is out of proportion to the severity of the initiating infection.
70
Risk factors for toxic shock syndrome
``` Being female Use of tampons Mastitis Sinusitis Osteomyelitis Burns Compromised immune system (eg. HIV) ```
71
Adjuncts to management that involve toxin/endotoxin
``` Clindamycin as an adjunct (prevents the synthesis of TSST) Intravenous immunoglobulin (to bind circulating TSST) ```
72
tests to do with meningitis if gram stain negative
``` Herpes Simplex PCR Mycobacterium Tuberculosis PCR Mycobacterial Stain and Cultures India Ink Stain, Cryptococcal Ag Fungal cultures Bacterial PCR ```
73
ways to decrease risk of CVC infection:
Intelligence use of CVCs (i.e. does the patient even need one?) Subclavian lines. Minimum number of lumens. Use of dedicated lumens for lipid infusions. Immunosuppressed patients or those with burns should have antibiotic-coated lines. For insertion, use aseptic technique and maximal barrier precautions. 0.5% chlorhexidine in 70% alcohol is the preferred cleaning agent. Handle ends of administration sets with gauze soaked in chlorhexidine). Review the line daily. Remove the line as soon as possible. Change lines early - ideally, every 7 days. Sterile, transparent semipermeable dressings Change dressings regularly (every 7 days for standard dressings)
74
Alternative pathogens causing pseudomembranous colitis
``` Strongyloides stercoralis Staphylococcus aureus Clostridium perfringens Yersinia CMV Entamoeba Listeria ``` All the enterohaemorrhagic diarrhoea organisms: - Salmonella - Shigella - Campylobacter - E.coli
75
treatment for moderate - severe pneumonia
beta lactam and macolide (eg azithromycin 500mgod) Continue for 7-10 days NB - mild/mod infection; ceph and azithro, 5 days
76
Aetiology of nosocomial infection in ICU:
Pneumonia: VAP or HAP Central line associated bacteraemia UTI due to indwelling catheters Sinusitis due to nasogastric tubes Acalculous cholecystitis due to parenteral nutrition Pressure area infections Meningitis or ventriculitis due to EVD infection C.difficile infections due to broad-spectrum antibiotic use Surgical site infections
77
Causes of raised lactate in sepsis
endogenous catecholamine release and used of adrenaline Circulatory faliure due to hypoxia and hypotension Cytopathic hypoxia - widespread microvascular shunting and mitochondrial failure inhibition of pyruvate dehydrogenase by endotoxin Coexistent liver disease